Lonza Group AG (LONN)

Currency in CHF
494.20
+8.60(+1.77%)
Closed·
LONN is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
482.70497.60
52 wk Range
454.60605.20
Key Statistics
Bid/Ask
493.00 / 498.80
Prev. Close
485.6
Open
486
Day's Range
482.7-497.6
52 wk Range
454.6-605.2
Volume
239.82K
Average Volume (3m)
163.91K
1-Year Change
-11.7815%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LONN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
675.78
Upside
+36.74%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Lonza Group AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. Its Small Molecules segment provides integrated development and manufacturing services for small molecule drug substances and their intermediates. This segment also supports customers across aspects of design, development, and manufacturing, such as particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. Its Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.

Compare LONN to Peers and Sector

Metrics to compare
LONN
Peers
Sector
Relationship
P/E Ratio
37.5x27.9x−0.5x
PEG Ratio
0.730.240.00
Price/Book
3.7x4.3x2.6x
Price / LTM Sales
5.2x3.8x3.1x
Upside (Analyst Target)
38.3%29.0%55.9%
Fair Value Upside
Unlock10.5%7.4%Unlock

Analyst Ratings

21 Buy
3 Hold
0 Sell
Ratings:
24 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 675.78
(+36.74% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
CLSA
Buy654.00+32.34%-Maintain27/02/2026
RBC Capital
Buy670.00+35.57%630.00Upgrade11/02/2026
HSBC
Buy700.00+41.64%720.00Maintain11/02/2026
Barclays
Buy670.00+35.57%-Maintain07/01/2026
Morgan Stanley
Buy650.00+31.53%625.00Upgrade25/11/2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 12.94%
Dividend Yield
0.84%
Industry Median 1.20%
Annualised payout
4.00
Paid annually
5-Years Growth
+10.76%
Growth Streak

Earnings

Latest Release
28/01/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / 3.78B
EPS Revisions
Last 90 days

People Also Watch

150.80
GALD
+1.69%
93.550
ERST
-0.64%
86.54
PKO
-0.14%
88.90
GALE
-1.11%
82.35
VTR
-0.42%

FAQ

What Is the Lonza Group (LONN) Share Price Today?

The Lonza Group stock price today is 494.20 CHF.

What Stock Exchange Does Lonza Group (LONN) Trade On?

Lonza Group is listed and trades on the Switzerland Stock Exchange.

What Is the Ticker (Stock Symbol) for Lonza Group?

The stock symbol (also called a 'ticker') for Lonza Group is "LONN."

Does Lonza Group Pay Dividends? What’s The Current LONN Dividend Yield?

Yes, LONN Pays Dividends to its Shareholders. The current Lonza Group dividend yield is 0.86%.

What Is the Current Lonza Group Market Cap?

As of today, Lonza Group market cap is 34.96B CHF.

What Is Lonza Group's (LONN) Earnings Per Share (TTM)?

The Lonza Group EPS is currently 12.94 (Trailing Twelve Months).

When Is the Next Lonza Group Earnings Date?

Lonza Group's next earnings report will be released on 16/04/2026.

Is LONN a Buy or Sell From a Technical Analyst Perspective?

Based on today's Lonza Group moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Lonza Group Stock Split?

Lonza Group has split 2 times. (See the LONN stock split history page for full effective split date and price information.)

How Many Employees Does Lonza Group Have?

Lonza Group has 19771 employees.

What is the current trading status of Lonza Group (LONN)?

As of 26/03/2026, Lonza Group (LONN) is trading at a price of 494.20 CHF, with a previous close of 485.60 CHF. The stock has fluctuated within a day range of 482.70 CHF to 497.60 CHF, while its 52-week range spans from 454.60 CHF to 605.20 CHF.

What Is Lonza Group (LONN) Price Target According to Analysts?

The average 12-month price target for Lonza Group is 675.78 CHF, with a high estimate of 815 CHF and a low estimate of 550 CHF. 21 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +36.74% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.